Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop ...
"This is a gamechanger for understanding and treating immune vulnerabilities in patients with lymphoma who have undergone cancer treatment -; and hopefully other disorders too." Led by Singh, the team ...